Pharmabiz8h
Rochester Institute of Technology hosts AI and Data Science Summit with Vellore Institute of Technology in Chennai
Rochester Institute of Technology hosts AI and Data Science Summit with Vellore Institute of Technology in Chennai: Our ...
Pharmabiz11h
TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa
TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa: Our Bureau, Mumbai ...
Pharmabiz12h
China NMPA grants expanded approval for Merck’s Gardasil for use in males 9-26 years of age to help prevent certain HPV-related cancers & diseases
China NMPA grants expanded approval for Merck’s Gardasil for use in males 9-26 years of age to help prevent certain HPV-related cancers & diseases: Rahway, New Jersey Friday, Ja ...
Pharmabiz6h
Mineralys Therapeutics gets US FDA nod to begin phase 2 trial of lorundrostat for OSA in patients with hypertension
Radnor, Pennsylvania Friday, January 10, 2025, 18:00 Hrs [IST] ...
Pharmabiz7h
IGC Pharma names IGC-AD1 phase 2 clinical trial for Alzheimer’s agitation as CALMA trial
IGC Pharma names IGC-AD1 phase 2 clinical trial for Alzheimer’s agitation as CALMA trial: Potomac, Maryland Friday, January 10, 2025, 16:30 Hrs [IST] IGC Pharma, Inc, an AI-powe ...
Pharmabiz3d
JCR Pharma & Modalis validate initial proof of concept in a joint research programme for development of a novel gene therapy for a CNS disease
JCR Pharmaceuticals Co., Ltd., a global specialty pharmaceuticals company, and Modalis Therapeutics Corporation, a forerunner in the field of epigenetic medicine, announced that they have validated ...
Pharmabiz3d
Acurx Pharma receives positive regulatory guidance from EMA for ibezapolstat phase 3 programme for C. difficile infection
Acurx Pharmaceuticals, Inc., a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, announced that it has ...
Pharmabiz3d
Biotech Showcase 2025 is set to convene in San Francisco for Biotech Investor Conference
Biotech Showcase 2025, an exciting and content-packed programme it dives deep into the future of biotechnology and healthcare innovation, will once again serve as the premier destination for global ...
Pharmabiz4d
ResMed launches AirSense 11, to advance digital health in sleep apnoea for Indians
ResMed, the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, has launched AirSense 11 in India. The company’s next-generation Continuous Positive ...
Pharmabiz3d
Zydus enters agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR to its template formulary
Zydus Lifesciences Ltd., a global innovation driven healthcare company, announced that it has entered into an agreement with CVS Caremark, a CVS Health company to add Zituvio, Zituvimet and Zituvimet ...
Pharmabiz3d
eMBR Genomics partners with Axio BioPharma to make MKLP1 Pro antibodies commercially available
In a milestone for cellular research, eMBR Genomics and Axio BioPharma announce the first commercial availability of MKLP1 Pro antibodies, KIF23 gene – the same tools used by the world’s leading ...
Pharmabiz3d
SunAct Cancer Institute ties up with Singapore’s CytoMed for phase 2 clinical trials on innovative Gamma Delta T-cell cancer therapy in India
SunAct Cancer Institute is excited to announce the start of phase 2 clinical trials on a groundbreaking treatment called Gamma Delta T-cell therapy. This trial, conducted in collaboration with CytoMed ...